𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy

✍ Scribed by Michiko Shindo; Arai Ken; Tadao Okuno


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
92 KB
Volume
85
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND.

To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN was conducted.


πŸ“œ SIMILAR VOLUMES


The effect of retreatment with interfero
✍ Hidenori Toyoda; Takashi Kumada; Satoshi Nakano; Isao Takeda; Keiichi Sugiyama; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

BACKGROUND. Interferon (IFN) has been reported to have beneficial long term effects that reduce the occurrence of hepatocellular carcinoma (HCC), even in patients who do not have complete responses to IFN. The authors evaluated the effect of retreatment with IFN-␣ on the long term prognoses of those

Clinical significance of hepatic HCV RNA
✍ Larghi, Alberto; Tagger, Alessandro; Crosignani, Andrea; Ribero, Maria Lisa; Bru πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-␣ (IFN-␣) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN

Association between high serum alanine a
✍ Kazuo Tarao; Yasushi Rino; Shinichi Ohkawa; Akio Shimizu; Setsuo Tamai; Kaoru Mi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 2 views

Many studies have demonstrated in animal experiments that persistent inflammation may accelerate the development of carcinoma. In this article, the question of whether the persistent elevation of serum alanine aminotransferase (ALT) levels (which represents the inflammatory necrosis of hepatocytes)